Microfluidics Device Market
Microfluidics Device Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Microfluidics Device Market Size and Growth
The global Microfluidics Device market is projected to reach $14.85 billion by 2026, growing at a CAGR of 19.2% during the forecast period. Key factors driving market growth include increasing demand for point-of-care testing, technological advancements in healthcare diagnostics, and the rising prevalence of chronic diseases. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche
◍ Abbott Laboratories
◍ Siemens Healthcare
◍ Agilent Technologies
◍ Fluidigm Corporation
◍ Bio-Rad Laboratories
◍ Cepheid
◍ Dolomite Centre
◍ Micronit Microfluidics
◍ Johnson & Johnson
◍ Becton, Dickinson And Company
The competitive landscape of the Microfluidics Device Market includes key players such as Roche, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Fluidigm Corporation, Bio-Rad Laboratories, Cepheid, Dolomite Centre, Micronit Microfluidics, Johnson & Johnson, and Becton, Dickinson And Company. These companies utilize Microfluidics devices for various applications in healthcare, research, and diagnostics, contributing to the growth of the market.
- Roche: $61.60 billion
- Abbott Laboratories: $33.27 billion
- Siemens Healthcare: $8.92 billion
Request Sample Report
